We used a previously characterized mouse tumour-initiating cell line, termed IENS-GFP (Ink4A/Arf−/− deleted plus EgfrvIII viral overexpression) (Bruggeman et al., 2007). The gene discussed is CDKN2A; the disease is neoplasm.